Stage IV Nonsmall-Cell Lung CancerJames R. Rigas
The 5-year survival of patients with small cell lung cancer is only 5%. The staging of small cell lung cancer is divided into limited stage and extensive stage (Box 64-3). Limited stage refers to disease that can be confined to one radiation port. At the time of presentation, ...
Small-celllung cancer(SCLC) is a disease in which cells in your lung begin growing out of control. It starts in nerve cells or cells that make hormones. About 10% to 15% of lung cancer cases are small-cell. The other kind is called non-small-cell lung cancer. They’re different in ...
在初步诊断为广泛期SCLC时,18%的患者有脑转移且2年后增至约80%。EORTC(European Organization for Research and Treatment of Cancer)的一项研究,将对化疗有反应的患者随机化分为2组,接受PCI或不接受PCI,发现PCI治疗组1年生存率为27.1%,未接受PCI者为13.3%。[49]在该研究中,PCI不仅减少脑转移的发生率也提高无...
Staging cancer provides important information about the outlook of the patient's condition and helps the doctor plan the best treatment. Although doctors stage other cancers from stage I to stage IV, small-cell lung cancer is classified into two stages. ...
Surgery plays an important role in the treatment of non–small-cell lung cancer (NSCLC) in the early stages of the disease [1]. However, surgical resection is not actively recommended for patients with stage IV NSCLC presently, despite the fact that systemic therapy has been regarded as the ...
Navigating treatment combinations in small-cell lung cancer The ETER701 trial demonstrates that a four-drug regimen, involving the addition of anti-angiogenesis therapy to immuno-chemotherapy, improves survival outcomes for extensive-stage small-cell lung cancer — but is more indeed better when it co...
GUIDELINE QUESTION: In patients with metastatic, stage IV non-small-cell lung cancer (NSCLC) does chemotherapy improve survival and quality of life? OBJECTIVE: To make recommendations about the role of chemotherapy in the treatment of metastatic (stage IV) NSCLC. OUTCOMES: Survival and quality of...
From June 1991 to August 1994, 61 patients with stage III unresectable non-small-cell lung cancer ( NSCLC ; 16 cases of stage IIIA with N2 bulky disease an... GV Scagliotti,U Ricardi,L Crinó,... - 《Cancer Chemotherapy & Pharmacology》 被引量: 5发表: 1996年 A Phase I/II Radiation...
Small-cell lung cancer (SCLC) is a deadly cancer associated with smoke exposure that has neuroendocrine (NE) cell properties and is pathologically, molecularly, biologically and clinically very different from other lung cancers. While most patients with SCLC respond initially to cytotoxic therapy, almo...